about
Models for thrombin generation and risk of diseaseFrom principle to practice: bridging the gap in patient profilingAnticoagulants and the propagation phase of thrombin generationFactor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation.The tissue factor requirement in blood coagulation.Thrombin generation profiles in deep venous thrombosis.Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastographyThe plasma hemostatic proteome: thrombin generation in healthy individuals.Cellular regulation of blood coagulation: a model for venous stasisThrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation.Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor compositionIs there value in kinetic modeling of thrombin generation? Yes.Empirical and theoretical phenotypic discrimination.Thrombin generation and bleeding in haemophilia AThe measurement and application of thrombin generation.Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.Biochemical markers of aging for longitudinal studies in humans.Tissue factor-dependent thrombin generation across pregnancy.Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosisFucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease.Modeling thrombin generation: plasma composition based approach.Platelet activation and aggregation: the importance of thrombin activity--a laboratory model.Computational modelling of clot development in patient-specific cerebral aneurysm cases.Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assayThe limits of simulation of the clotting system.Platelet-dependent thrombography: a method for diagnostic laboratories.Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A.High dose factor VIIa improves clot structure and stability in a model of haemophilia B.Stochastic modeling of blood coagulation initiation.Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation.In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus
P2860
Q27013171-414470B6-0B39-4B70-B18A-786EC093D3B3Q27318447-5605DDE8-4A72-4725-B177-D57270C872F7Q28742536-7B3565DC-ED2D-4C78-BC62-559B9FF0AF09Q34128442-6128B7CA-3383-4F19-A4FA-1EC42121118CQ34360277-81FDC585-3A88-4E5D-9EDD-600D35B31C59Q34469944-1B4CBB02-A94D-41CD-9358-67C13E37E526Q34469949-4E5F5E28-5676-49DC-99AD-841634955B0DQ34481022-2E5417F8-0D36-467C-B852-D54C35C3DC9FQ34541636-254C2723-EF29-4C8C-9641-DA2A3BD6A824Q35166472-EA23B62A-A7C1-4DC2-BFEB-08AEA7D96A28Q35243446-9599A11B-CA09-4513-BAB2-3CB49C6061F3Q36008892-CB9020F8-877F-4E6C-9BD6-82C2FA863200Q36090193-675FFB12-91C9-46BC-B817-B85DE48A09A7Q36090217-C79789B7-39F7-404C-A61B-562B1AF51398Q36237649-34C6BD91-019A-418B-BDE5-4E737C55866DQ36283835-A11AC433-E10D-4735-A50C-EB89E007B8F7Q36370881-05D7A906-7732-4D76-88C2-3D7AFBE1E87EQ36449881-E9D68957-4846-488B-8673-0CBA3D8D5290Q36865746-9B9EBF74-E2A9-4778-8531-3EF2D8FF85C0Q36906388-C8231268-2ACB-4788-9668-3C17FFA6466BQ36941082-29E29A11-61E4-452C-8C7D-A11D1095A277Q37373064-939FEA94-82CE-488E-B170-C31DF5C9C088Q37419736-488B8084-DA16-4436-9FA8-7828ABE550E7Q38077217-71EF9AEA-3523-404F-B898-38DB642E8EF0Q38161459-950AAD87-F042-4EE3-8BC6-7646A6ECF505Q39471623-F8075EDC-1235-4704-9735-1D4CF9E73574Q40216500-38CFA17B-D67D-4706-968D-88B4812E17F0Q41988456-19BA7626-C20E-4231-A270-547C3E089F42Q45858397-3EE8DDC2-0CBE-488D-B791-B7F4AC190D01Q45861170-981C3B52-EB26-4512-8DFC-F21FE5BB5177Q45862449-517D7958-8341-4C9B-9E76-CD8762FECE87Q45863550-FAFC6CDB-B9F2-40A8-93E3-EC182A3876EAQ45889198-A037C6C0-1FD2-48C4-A022-49D656E91662Q51283347-91405D00-7D4E-42CF-BB7B-16BEC9731CB4Q51555879-51ED9F10-8BF3-4149-903E-4C04EDB99BF3Q53570003-24FB5F30-2D44-49D5-822C-85C49CA0D7ACQ57822378-8DF2D692-CEA4-44C7-9581-02B8019AF8B1
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Thrombin generation: phenotypic quantitation.
@en
Thrombin generation: phenotypic quantitation.
@nl
type
label
Thrombin generation: phenotypic quantitation.
@en
Thrombin generation: phenotypic quantitation.
@nl
prefLabel
Thrombin generation: phenotypic quantitation.
@en
Thrombin generation: phenotypic quantitation.
@nl
P2093
P2860
P1476
Thrombin generation: phenotypic quantitation.
@en
P2093
Brummel-Ziedins KE
Pouliot RL
P2860
P304
P356
10.1046/J.1538-7933.2003.00576.X
P577
2004-02-01T00:00:00Z